Mycophenolate Mofetil
NDC 16571-282, Mycophenolate Mofetil, powder, for suspension, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-282
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213955
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-282 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MYCOPHENOLATE MOFETIL200 mg/mL
Pharmacologic classes
Antimetabolite Immunosuppressant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-282-17 | 16571028217 | 1 BOTTLE, PLASTIC in 1 CARTON (16571-282-17) / 225 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/bbe03c1d-02ca-4d39-ace6-6f47e916d5b7
Use it
Look up 16571-282 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-282 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-282. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.